Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Neurología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
INTERVENTIONAL
Inicio: 30 de nov de 2015
ID: NCT02614261
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of SLV308 as Adjunct Therapy to Levodopa in Patients With Parkinson's Disease Experiencing Motor Fluctuations.
INTERVENTIONAL
Inicio: 1 de mar de 2007
ID: NCT00406588
Terminado
Fase 3
ClinicalTrials.gov
Randomized Open Label of Ofatumumab and Bendamustine Combination Compared With Bendamustine Monotherapy in Indolent B-cell Non-Hodgkin's Lymphoma Unresponsive to Rituximab or a Rituximab-Containing Regimen During or Within Six Months of Treatment
INTERVENTIONAL
Inicio: 26 de ago de 2010
ID: NCT01077518
Terminado
Fase 3
ClinicalTrials.gov
A Placebo-Controlled, Double-Blind, Parallel-Group, 24 Month Study With an Open-Label Extension Phase to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Subjects With Early Alzheimer's Disease
INTERVENTIONAL
Inicio: 20 de oct de 2016
ID: NCT02956486
Completado
Fase 3
ClinicalTrials.gov
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
INTERVENTIONAL
Inicio: 1 de oct de 2013
ID: NCT01955161
Completado
Fase 4
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled 52-Week Study to Assess Adverse Events of Special Interest in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Receiving Belimumab
INTERVENTIONAL
Inicio: 27 de nov de 2012
ID: NCT01705977
Completado
Fase 2
ClinicalTrials.gov
A Two-Phase, Double Blind, Placebo-Controlled, Randomized, Crossover Study of the Safety and Efficacy of Intra-Oral NH004 Films for the Short-Term Relief of Sialorrhea Symptoms in Parkinson's Disease Patients
INTERVENTIONAL
Inicio: 1 de mar de 2008
ID: NCT00761137
Activo, no recluta
ClinicalTrials.gov
Long-term Follow-up of Subjects With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product
OBSERVATIONAL
Inicio: 22 de ene de 2016
ID: NCT02698579
Activo, no recluta
Fase 2
ClinicalTrials.gov
A Phase 2, Parallel Group, Randomized, Double- Blind, Placebo-Controlled, 3-Arm, Multicenter Treatment Study to Evaluate the Efficacy and Safety of GSK4527226 [AL101] Intravenous Infusion Compared With Placebo in Patients With Early Alzheimer's Disease
INTERVENTIONAL
Inicio: 20 de oct de 2023
ID: NCT06079190
Terminado
Fase 3
ClinicalTrials.gov
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Study of Crenezumab in Patients With Prodromal to Mild Alzheimer's Disease
INTERVENTIONAL
Inicio: 29 de mar de 2017
ID: NCT03114657
Reclutando
Fase 1
ClinicalTrials.gov
A Phase I, 2-Part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-ascending Doses of Intrathecally Administered RG6496 in a Randomized, Placebo-controlled, Investigator/Participant-blind Study With an Open-label Extension in Huntington's Disease Gene Expansion Carriers
INTERVENTIONAL
Inicio: 19 de nov de 2025
ID: NCT07246941
Retirado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Open-Label Study to Evaluate the Efficacy and Safety of AMZ002, Compared to Vigabatrin, in the Treatment of Infantile Spasms
INTERVENTIONAL
Inicio: 1 de abr de 2023
ID: NCT05128344
Completado
ClinicalTrials.gov
International Observational Retrospective Case Review of Efficacy and Safety of Switch Between Agalsidase Beta to Agalsidase Alfa for Enzyme Replacement in Males and Females With Anderson-Fabry Disease
OBSERVATIONAL
Inicio: 1 de dic de 2010
ID: NCT01268241
Terminado
Fase 2
ClinicalTrials.gov
A Multicenter, Long-term Extension Study to Evaluate the Safety, Tolerability, and Efficacy of AL002 in Participants With Alzheimer's Disease
INTERVENTIONAL
Inicio: 4 de ene de 2023
ID: NCT05744401
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Rater-Blinded Study Comparing Two Annual Cycles of Intravenous Alemtuzumab to Three-Times Weekly Subcutaneous Interferon Beta-1a (Rebif®) in Treatment-Naïve Patients With Relapsing-Remitting Multiple Sclerosis
INTERVENTIONAL
Inicio: 1 de ago de 2007
ID: NCT00530348
Completado
Fase 3
ClinicalTrials.gov
COMPAS: A Phase III Study to Demonstrate Efficacy of GSK Biologicals' 10-valent Pneumococcal Vaccine (GSK1024850A) Against Community Acquired Pneumonia and Acute Otitis Media
INTERVENTIONAL
Inicio: 28 de jun de 2007
ID: NCT00466947
Terminado
Fase 3
ClinicalTrials.gov
A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People
INTERVENTIONAL
Inicio: 1 de ene de 2011
ID: NCT01259297
Reclutando
Fase 1
ClinicalTrials.gov
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Exosome Intranasal Instillations for the Treatment of Stroke
INTERVENTIONAL
Inicio: 1 de feb de 2022
ID: NCT05158101
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Open-label, Long-term, Safety, Tolerability and Efficacy Study of Retigabine in Adult Epilepsy Patients With Partial-onset Seizures (Extension of Study VRX-RET-E22-301)
INTERVENTIONAL
Inicio: 1 de may de 2006
ID: NCT00310375
Desconocido
ClinicalTrials.gov
Delto-Tricipital Compression Syndrome: A Randomized Treatment Comparison Trial of Dextrose Injection Versus Physical Therapy.
INTERVENTIONAL
Inicio: 1 de ene de 2015
ID: NCT02331069
Anterior
1
...
22
23
24
...
434
Siguiente
Filtros